April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Ultra widefield fluorescein angiographic findings in patient with recurrent vitreous hemorrhage after diabetic vitrectomy
Author Affiliations & Notes
  • Dong Yoon Kim
    Asan medical center, Seoul, Republic of Korea
  • Yoon Jeon Kim
    Asan medical center, Seoul, Republic of Korea
  • Soo Guen Joe
    Asan medical center, Seoul, Republic of Korea
  • Joo Yong Lee
    Asan medical center, Seoul, Republic of Korea
  • June-Gone Kim
    Asan medical center, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Dong Yoon Kim, None; Yoon Jeon Kim, None; Soo Guen Joe, None; Joo Yong Lee, None; June-Gone Kim, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 242. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dong Yoon Kim, Yoon Jeon Kim, Soo Guen Joe, Joo Yong Lee, June-Gone Kim; Ultra widefield fluorescein angiographic findings in patient with recurrent vitreous hemorrhage after diabetic vitrectomy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):242.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To analyze the difference in ultra-widefield fluorescein angiographic findings between patients with recurrent post vitrectomy diabetic vitreous hemorrhage (PVDVH) and patients with no post vitrectomy diabetic vitreous hemorrhage (NPVDVH).

 
Methods
 

Retrospective review was conducted to the patients who were underwent vitrectomy for diabetic vitreous hemorrhage. Patients were categorized as PVDVH when vitreous hemorrhage was recurred after diabetic vitrectomy. Age-matched control patients who underwent diabetic vitrectomy and did not recurred vitreous hemorrhage after vitrectomy were assigned to NPVDVH. Baseline characteristics such as best corrected visual acuity (BCVA), follow-up duration, HbA1C level were compared between groups. And by using ultra-widefield fluorescein angiography, peripheral angiographic findings such as peripheral neovascularization, non-perfusion and late peripheral vascular leakage were analyzed.

 
Results
 

Seventeen eyes were PVDVH and 24 eyes were NPVDVH. BCVA at preoperative, 3 month after postoperative and final visit were not different between two groups. Follow-up duration and HbA1C level were not significantly different. Mean intravitreal bevacizumab injections for PVDVH were 7.24 ± 5.95. The rate of peripheral neovascularization was significantly different between groups (PVDVH ; 35.5%, NPVDVH ; 8.3%, p =0.049). The rate of peripheral non-perfusion was significantly greater in PVDVH than in NPVDVH (PVDVH ; 76.5%, NPVDVH ; 37.5%, p =0.014). And the rate of late peripheral vascular leakage was also significantly greater in PVDVH than in NPVDVH (PVDVH ; 88.2%, NPVDVH ; 29.2%, p<0.001).

 
Conclusions
 

Compared with diabetic vitrectomized eyes that did not recurred after diabetic vitrectomy, PVDVH eyes had higher rate of peripheral neovascularization, peripheral non-perfusion and late peripheral vascular leakage. Considering the high rate of peripheral neovascularization, late peripheral vascular leakage and peripheral non-perfusion, increased vascular endothelial growth factor (VEGF) level might be associated with post vitrectomy diabetic vitreous hemorrhage.

 
Keywords: 550 imaging/image analysis: clinical • 499 diabetic retinopathy • 748 vascular endothelial growth factor  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×